For businesses struggling to get their artificial intelligence projects into production, automation and orchestration could be the unifying forces that get them a return on their investment. UiPath ...

UiPath is rated a Buy due to its strategic shift towards integrating generative AI into its RPA platform, driving future growth. PATH's new partnerships with Snowflake, Google, Microsoft, and Nvidia ...

Palantir is growing like a weed, but its valuations are getting overheated. UiPath faces tough near-term challenges, but its stock looks a lot cheaper. Both stocks are risky plays in this frothy ...

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year ...

Asia-Pacific enterprises are rapidly advancing AI adoption, with investments expected to grow from nearly US$90 billion in 2025 to US$176 billion by 2028, primarily focused on building agentic AI ...